Abstract
Pancreatic carcinoma has the poorest prognosis in all the digestive cancers, and the management is still challenging. In recent years, the rapid development of surgical technique has led to the increase in the resection rate and the significant decrease in perioperative mortality and morbidity. However, the prognosis of pancreatic carcinoma has not been improved. Nowadays, the treatment strategy of pancreatic carcinoma has been changed from first into the mode of multidisciplinary team. If 1 mm rule was used as the standard protocol for assessment of resection margins, most of the pancreatic resection were therefore R1 resections. Neoadjuvant therapy is advocated for patients who meet specific characteristics. Under the guidance of the concept of precision medicine, surgical treatment of pancreatic carcinoma should be changed from the modes of morphology and surgery to the modes biology and oncology. Key words: Pancreatic neoplasms; Surgical procedures, operative; Multidisciplinary team
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
